Refers to a compound of formula (i), where X is the formula (ii), (iii), among others. Preferred compounds are 4 - (4 - [(1e) - 4 - (1.8 - diazaespiro [4.5] dec-1-yl) but - 1 - 1 - il - 2-methylbenzyl}] - 5 - (propan-2-yl) - 1H pyrazole - 3 - il beta D - glucopiranosido 4 - (4 - [(1e) - 4 - (2.8 - diazaespiro [4.5] dec-8-yl) but - 1 - 1 - il - 2-methylbenzyl}] - 5 - (propan-2-yl) - 1H pyrazole - 3 - il beta D - glucopiranosido, among others.It also relates to a Pharmaceutical composition that is useful for the treatment of Type 1 diabetes.SE REFIERE A UN COMPUESTO DE FORMULA (I), DONDE X ES LA FORMULA (II), (III), ENTRE OTROS. SON COMPUESTOS PREFERIDOS 4-{4-[(1E)-4-(1,8-DIAZAESPIRO[4.5]DEC-1-IL)BUT-1-EN-1-IL]-2-METILBENCIL}-5-(PROPAN-2-IL)-1H-PIRAZOL-3-IL BETA-D-GLUCOPIRANOSIDO 4-{4-[(1E)-4-(2,8-DIAZAESPIRO[4.5]DEC-8-IL)BUT-1-EN-1-IL]-2-METILBENCIL}-5-(PROPAN-2-IL)-1H-PIRAZOL-3-IL BETA-D-GLUCOPIRANOSIDO, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA QUE ES UTIL PARA EL TRATAMIENTO DE DIABETES TIPO 1.
